跳至主要内容
临床试验/NCT03899454
NCT03899454Unknown2 期

Randomized Clinical Trial of the Effect of G. Mangostana L Rind and Solanum Lycopersicum Fructus Extract to Prevent Exercise-induced Oxidative Stress

Universitas Negeri Semarang1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
30
试验地点
1
主要终点
Change ergo-cycle exercise test response to MDA level after 4 weeks treatment

研究概览

简要总结

Treatments are an administration of a mixed extract of Garcinia mangostana 400mg and Solanum Lycopersicum Fructus 200mg (OKSI(R) POM TR 193324351) and placebo control.

详细描述

Double-blinded Randomized Clinical Trial

The population of study will involve sedentary men, the student in Universitas Negeri Semarang aged 18-25 years old, targetted populations are 30 subjects consist of 15 treatment group and the rest 15 placebo-control group. Voluntary sampling will be conducted. Information to the candidates delivered directly, leaflets, and social media broadcasting.

Two arm treatment to be given is an administration of a mixture extract of Garcinia mangostana 400mg and Solanum Lycopersicum Fructus 200mg (OKSI(R) POM TR 193324351) and placebo control.

The administration of extract treatment and placebo will be given for four weeks.

The primary effect that will be observed is the changes in malondialdehyde (MDA) and high-sensitivity Cardiac-Troponin I (hs-cTnI) level after an ergo-cycle exercise test.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • sedentary lifestyle
  • apparently healthy person
  • willing to use the smart-phone application for diet and physical activity monitoring

排除标准

  • pathological appearance in ECG

研究组 & 干预措施

Extract administration

Experimental

administration of a mixed extract of Garcinia mangostana 400mg and Solanum Lycopersicum Fructus 200mg (OKSI(R) POM TR 193324351)

干预措施: Garcinia-mangostana-L-rind and Solanum-Lycopersicum-Fructus mixture-extract (Drug)

Control

Placebo Comparator

Placebo

干预措施: Placebo Control (Drug)

结局指标

主要结局

Change ergo-cycle exercise test response to MDA level after 4 weeks treatment

时间窗: 4 weeks

measuring exercise-induced oxidative stress, based on pre-and post-exercise MDA levels

Change ergo-cycle exercise test response to hs-cTnI level after 4 weeks treatment

时间窗: 4 weeks

measuring exercise-induced oxidative stress, based on pre-and post-exercise hs-cTnI levels

次要结局

  • Change from baseline MDA levels after 4 weeks treatment(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mahalul Azam

Principle Investigator

Universitas Negeri Semarang

研究点 (1)

Loading locations...

相似试验